Enzymotec To Report Fourth Quarter And Fiscal Year 2013 Financial Results
2/4/2014 9:06:52 AM
MIGDAL HA'EMEQ, Israel, Feb. 4, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2013 on Thursday, February 13, 2014, before the market opens. Following the release, the Company will host a conference call to discuss these results with additional comments and details. Participating on the call will be Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by